Shivalik Bimetal Q1 Beat Isn't About the Quarter — It's About the Margin Shift the Market Missed

The market has been pricing Shivalik Bimetal Controls as a commodity strip maker caught between tariff uncertainty and flat domestic switchgear demand. That story isn't wrong — it's just already behind the company.

On August 7, Shivalik reported Q1 FY27 results that sent the stock up 20% to ₹920 in a single session, reaching the top of its 52-week range. Revenue climbed 33% year-over-year to ₹182.2 crore. Profit after tax jumped 45% to ₹33 crore. Consolidated net profit margin expanded to 18.1%, up 144 basis points from a year earlier.

The tape move is the easy part. What matters is what the margins are telling you about the next 12 months — and whether the stock at ₹920 still has room to run if the operating inflection holds.

The shift that actually changed the business

For most of its history, Shivalik has been a maker of thermostatic bimetal strips — the heat-sensing elements inside circuit breakers and household appliances. It's India's dominant player in that space, with roughly 90% domestic market share and a 16% global share. The business is stable, but it doesn't grow fast, and it doesn't carry outsized margins.

The thing that changed is the product mix. Last year, component supply — higher-value finished parts rather than raw strip — accounted for 55% of the business. In Q1 FY27, it was 65%. That single shift is doing the heavy lifting.

Moving from strip to component improves price realization per kilogram by 10% to 12% in the shunt business alone. The standalone gross margin for the quarter was 51.48%, up 355 basis points. EBITDA margin expanded 33 basis points to 23.7%. These are not raw-material pass-through gains. They're structural, coming from a business model that's climbing its own value chain.

The shunt resistor segment — precision current sensors used in EV battery management systems and smart electricity meters — grew 18.7% to ₹68.2 crore. Management said 70-75% of that growth came from value-added component conversion, not commodity price inflation. That distinction matters because it means the margin expansion is repeatable, not a one-off metal price windfall.

The recovery nobody priced in

The geographic breakdown in the quarter tells the real story about what the market had written off.

Shunt revenue from the Americas recovered 30% year-over-year to ₹15.8 crore. That's the region that was "soft" through most of FY26, where channel recalibration and tariff noise had muted call-offs. The recovery is early — management called it a 30% improvement, not a normalization — but it's the first sign that the tariff-driven pullback is fading.

Europe was louder. Shunt revenue grew 72% to ₹10.75 crore. India's domestic shunt business grew 22.8%, fed by the government's program to install 250 million smart meters between 2025 and 2027, with Shivalik components sitting in roughly 70% of the relay bill-of-materials.

Asia was the weak spot, with shunt revenue declining 15%. The legacy bimetal business grew a modest 7.4%. Bimetals are the "profit engine since 1984," in management's words, but they're no longer the growth story.

The cash-flow tension

Here's where the setup gets more complicated. FY26 free cash flow — operating cash flow minus capital expenditures, the actual cash a business generates for shareholders after funding its own growth — fell to ₹214 crore from ₹617 crore in FY25. Operating cash flow was ₹565 crore. The drop came from a spike in investing cash flow to ₹746 crore as the company funded expansion and working capital for its higher-value product mix.

The balance sheet is intact. Cash stands at ₹105 crore against ₹59 crore of consolidated debt. Net worth grew ₹75 crore in FY26 to ₹481 crore. Working capital collection days actually improved to 83 from 92. But net working capital days sit at 245, which is long — the business holds inventory for roughly six months while converting receivables in about three.

The question is whether the working capital and capex investment of FY26 pays off in FY27 and FY28 as higher-margin component revenue runs through the existing capacity. Management said the current asset base can support over ₹1,300 crore in revenue without major greenfield investment. Shunt capacity utilization is around 70% and expandable within two to three months. Bimetal utilization sits at 40-45%, meaning output could more than double in that segment without new plants.

The Pune facility and the second revenue curve

The other catalyst embedded in this quarter is the new Pune facility. The company received its Consent to Operate from the Maharashtra Pollution Control Board on August 7, the same day as the earnings release. Phase I requires ₹20-25 crore in capex — small on this balance sheet — and is expected to be fully operational by October FY27.

The facility will produce printed circuit board assemblies and busbar connectors for EV battery systems, power distribution units, and inverters. Management projects the cell connecting systems business could generate ₹150-200 crore in revenue by Year 2. That's material: if realized on a ₹7-8 crore base FY27 revenue, it adds 2-3% to the top line in Year 1 and could push into double-digit contribution by Year 3.

The margins on this business will be lower — management flagged EBITDA margins 8-10 percentage points below core products. But the revenue visibility is stronger because it ties into existing automotive customer relationships with Bosch, Continental, and Denso. The real value is that it moves Shivalik further from a materials play into a systems supplier, which is what commands higher multiples in this space.

The valuation problem

This is where the tape and the thesis collide. At ₹920, the stock trades at roughly 40 times earnings for FY27, assuming 25% revenue growth and an 18% net margin. On FY26 earnings of ₹16.64 per share, the trailing multiple is 55 times.

The stock is up 76% over the past year. The 20% gap on the earnings release brought it to its 52-week high. That move already prices in a lot of the margin story.

But the old multiple — the one the market was using before the component shift took hold — was still in the low-40s through early 2026, when the stock was around ₹592 and analysts were writing about tariff headwinds and muted global demand. The rerating hasn't been mechanical; it's been driven by margin proof. If FY27 delivers the 20-30% revenue growth management has guided to, and margins hold at 17-19% as the product mix stabilizes, FY27 EPS lands between ₹21 and ₹24. At a multiple in the mid-40s — reasonable for a zero-debt niche manufacturer with 45% quarterly profit growth — that supports ₹920-₹1,080.

The optionality is FY28, when Pune comes online and component share creeps past 70%. If FY28 EPS pushes toward ₹28-30 and the multiple holds at 42-45x, the range is ₹1,170-₹1,350. That's the inflection thesis: not a one-quarter surprise, but a two-year margin migration that the stock only partially reflects today.

What could break it

Three things. First, customer concentration risk in shunts. Vishay — which buys roughly 40% of Shivalik's shunt output — supplies shunts to top global EV manufacturers. Any disruption to Vishay's order flow, whether from US tariff shifts or a global EV slowdown, would show up in volumes within two quarters. Management says the largest single customer exposure is now under 20%, but the Vishay pipeline matters more than the headline concentration ratio.

Second, the new Pune business carries lower margins. If it ramps faster than core product growth, it drags blended margins down and removes the operating leverage that's driving this thesis. Management said 8-10 percentage points lower EBITDA, so the mix matters. You'd want to see core shunt and bimetal margins holding or expanding even as Pune contributes revenue.

Third, the single-site manufacturing risk. All production is currently in Solan, Himachal Pradesh. A geological event, power disruption, or policy change in the state would knock out the entire operation. Pune diversifies that risk, but only once it's operational — likely October FY27.

The setup

The market is still partially pricing the old story — a commodity strip maker wrestling with tariffs and flat domestic demand — while the operating evidence points to something different. Component share up from 55% to 65%. Gross margins above 51%. Americas recovery starting. A Pune facility with regulatory approval in hand and ₹150-200 crore in projected Year 2 revenue. Margins expanding despite higher employee and other costs tied to capacity investment.

The risk is entry. At ₹920, the stock is at its 52-week high after a 76% run over 12 months. Chasing a 20% gap day is rarely clean risk mechanics. If the stock retraces toward ₹750-800 — roughly its July 2026 trading range, or about 35-38 times FY27E earnings — that would be a more defined entry point.

Tripwire: two consecutive quarters of flat or declining component revenue share, or EBITDA margins contracting below 20%. Either one would signal the margin story is stalling, not accelerating. Cut without ego.

Target range for FY28E: ₹1,150-1,250, assuming 25% revenue growth through FY27, Pune contributing ₹150-200 crore in FY28, and a forward multiple in the low-40s. Timeframe: 12-18 months.

This isn't about excitement. It's about a business that's moving up its own value chain while the market hasn't fully adjusted its multiple to reflect the new margin reality. The question at current levels isn't whether the thesis is right. It's whether the entry still makes sense.